Osocimab (BAY-1213790)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 03:19, 31 January 2020 by Jwarner (talk | contribs) (Created page with "==Mechanism of action== Anti-Factor XIa antibody ==Preliminary data== ===Venous thromboembolism=== # '''FOXTROT:''' Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freita...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mechanism of action

Anti-Factor XIa antibody

Preliminary data

Venous thromboembolism

  1. FOXTROT: Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. link to original article PubMed
Retrieved from "https://hemonc.org/w/index.php?title=Osocimab_(BAY-1213790)&oldid=42599"